Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

2.03
Delayed Data
As of May 29
 +0.03 / +1.50%
Today’s Change
0.61
Today|||52-Week Range
3.50
+141.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line30.6M-114.4M-107.0M-52.7M
 
 
 
 
 
Depreciation1.7M2.5M3.8M6.2M
 
 
 
 
 
Total Other Cash Flow10.4M10.9M5.4M10.8M
 
 
 
 
 
Funds From Operations42.7M-101.0M-97.8M-35.7M
 
 
 
 
 
Funds From/For Other Operating Expenses16.2M4.7M-13.4M19.2M
 
 
 
 
 
Net Cash Flow - Operating Activities26.5M-105.7M-84.4M-54.8M
 
 
 
 
 
 
InvestingIncrease In Investments-376.3M-194.6M-175.4M-42.3M
 
 
 
 
 
Decrease In Investments234.8M339.8M191.1M109.8M
 
 
 
 
 
Capital Expenditures-2.6M-9.9M-3.7M-12.9M
 
 
 
 
 
Fixed Asset Disposal0.00----191.0K
 
 
Net Cash Flow Investing-144.1M135.2M12.1M54.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.003.7M0.008.6M
 
 
 
Long Term Debt Reduction0.00-2.2M-7.1M-7.8M
 
 
 
 
Net Proceeds Stock Sale115.4M1.6M53.6M191.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00465.0K0.00
 
 
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing115.4M3.1M47.0M1.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---26.0K26.0K0.00
 
 
 
 
Net Change In Cash-2.3M32.7M-25.3M882.0K
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account